Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis)
Sultan, M., Al Salam, F., Hassan, D., Abdulla, H., Abd El-Rahim, M., Mansour, H., Hussein, N. (2010). Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis). EKB Journal Management System, 38(1), 1-12. doi: 10.21608/ejhm.2010.17362
Maha M. Sultan; Fatma M. Abd Al Salam; Doaa A Hassan; Hodaa S. Abdulla; Marwa M. Abd El-Rahim; Hyam H. Mansour; Neama R. Hussein. "Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis)". EKB Journal Management System, 38, 1, 2010, 1-12. doi: 10.21608/ejhm.2010.17362
Sultan, M., Al Salam, F., Hassan, D., Abdulla, H., Abd El-Rahim, M., Mansour, H., Hussein, N. (2010). 'Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis)', EKB Journal Management System, 38(1), pp. 1-12. doi: 10.21608/ejhm.2010.17362
Sultan, M., Al Salam, F., Hassan, D., Abdulla, H., Abd El-Rahim, M., Mansour, H., Hussein, N. Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis). EKB Journal Management System, 2010; 38(1): 1-12. doi: 10.21608/ejhm.2010.17362

Assessment of Proinflammatory Th1 Cytokines (IL18-IFN ) and Th2‌ Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis)

The Egyptian Journal of Hospital Medicine
Article 1, Volume 38, Issue 1, January 2010, Page 1-12  XML PDF (400.06 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2010.17362
View on SCiNiTO View on SCiNiTO
Authors
Maha M. Sultan1; Fatma M. Abd Al Salam1; Doaa A Hassan1; Hodaa S. Abdulla2; Marwa M. Abd El-Rahim2; Hyam H. Mansour2; Neama R. Hussein3
1Department of Dermatology and Venereology Faculty of Medicine for Girls – Al-Azhar Univesity
2Department of General Medicine Faculty of Medicine for Girls – Al-Azhar Univesity
3Department of Clinical Pathology Faculty of Medicine for Girls – Al-Azhar Univesity
Abstract
Objective: Several cytokines play a role in the production of autoantibodies and the pathogenesis of rheumatic diseases including systemic lupus erythematosus (SLE),  rheumatoid arthritis (RA) and systemic sclerosis (SS). This study investigated serum concentration of the proinflammatory Th1 cytokine; IL18 and its inducer IFNg, the study also investigated serum concentration of proinflammatory Th2­ cytokine; IL13, to explain the role of Th1 and Th2 in the pathogenesis of autoimmune rheumatic diseases (SLE, RA and SS)
Patients and methods: IL18, IFNg and IL13 levels were evaluated by enzyme linked immunosorbent assay (ELISA). Four groups were included in this study.
Group I: Comprised (15) patients of SLE. Group II: Comprised (15) patients of RA. Group III: Comprised (15) patients with SS. Group IV: Control group consisted  of (15) sex and age matched healthy controls.
Results: Serum levels of IL18 was significantly higher in SLE (3138.200± 1413.096 pg/ml)& RA(3336.667± 921.839 pg/ml) than control group(86.647± 35.370 pg/ml ), while IL18­ in SS had no statistically significant difference between patients (103.634± 50.593 pg/ml)  and control group (86.647± 35.370 pg/ml).The cut off level  was 257.75 pg/ml .                            
IFNg was significantly higher in SLE patients (5.439±1.430 IU/ml) and RA patients (2.973± 0.598 IU/ml ) than control group(0.580 ± 0.234 IU/ml) ,while IFNg  in SS had no statistically significant difference (0.592± 0.245IU/ml) than control group (0.580 ± 0.234 IU/ml) .The cut off level was1.2 IU/ml .
As regard IL13 it  was significantly higher in SLE patients (55.673±6.892 pg/ml) ,RA patients (59.587±12.183 pg/ml) and SS (61.550± 12.047 pg/ml) than control group (21.427± 7.274 pg/ml ) .The cut off level was 44.4 pg/ml .There was significant positive correlation of IL18/ IL13 and IFNg / IL13  ratio in SLE and RA , while significant negative correlation of IL18/ IL13  and IFNg / IL13 ratio in SS.
Conclusion: There was a significant increase of both Th1 cytokines (IL18 and IFNg) and Th2­ cytokine (IL13) in SLE and RA with Th1 predominance,while predominance of Th2­ cytokine (IL13) in SS than  Th1 cytokine (IL18 and IFNg). This result suggests that IL18, INFg and IL13  could be involved in the pathogenesis of autoimmune rheumatic diseases.
 


 
Keywords
SLE; RA; SS; IL18; IFNg and IL13
Statistics
Article View: 200
PDF Download: 361